Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2022 09:00 ET | Source: AGC Biologics

Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate

Seattle, March 31, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with...
February 08, 2022 19:00 ET | Source: AGC Biologics

AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material

Heidelberg, Germany, Feb. 08, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded...
January 18, 2022 09:05 ET | Source: AGC Biologics

AGC Biologics Names Regina Choi-Rivera New General Manager of Boulder, Colorado Mammalian Production Facility

Boulder, Colo., Jan. 18, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Regina Choi-Rivera as...
December 20, 2021 08:05 ET | Source: AGC Biologics

AGC Biologics Receives Transatlantic Award for Investments in Milan Biopharmaceutical Industry

Milan, Dec. 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has won the 2021...
December 13, 2021 20:05 ET | Source: AGC Biologics

I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project

Seattle, Dec. 13, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with I-MAB...
December 01, 2021 09:03 ET | Source: AGC Biologics

4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab

Seattle, Dec. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with 4TEEN4...
November 01, 2021 09:03 ET | Source: AGC Biologics

AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer

Seattle, Nov. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Jean-Baptiste Agnus has been...
September 13, 2021 19:57 ET | Source: AGC Biologics

AGC Biologics Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility

Heidelberg, Germany, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced expansion plans...
August 20, 2021 13:39 ET | Source: AGC Biologics

AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site

COPENHAGEN, Aug. 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new...
August 09, 2021 13:00 ET | Source: AGC Biologics

AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site

LONGMONT, Aug. 09, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new leadership appointment...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right